Magazine: The journey of first generics
Pharmaceutical Technology
JUNE 6, 2023
With two historic FDA approvals for RSV vaccines in the last two months, this issue’s lead interview addresses the pertinent question of access— how to ensure eligible individuals across the world get this vaccine. Don’t miss the special thematic supplement that inspects the evolving role of cybersecurity in the pharmaceutical industry.
Let's personalize your content